These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Left ventricular assist device as destination therapy in doxorubicin-induced cardiomyopathy. Simsir SA; Lin SS; Blue LJ; Gockerman JP; Russell SD; Milano CA Ann Thorac Surg; 2005 Aug; 80(2):717-9. PubMed ID: 16039240 [TBL] [Abstract][Full Text] [Related]
14. Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiocardiography. Alexander J; Dainiak N; Berger HJ; Goldman L; Johnstone D; Reduto L; Duffy T; Schwartz P; Gottschalk A; Zaret BL N Engl J Med; 1979 Feb; 300(6):278-83. PubMed ID: 759880 [TBL] [Abstract][Full Text] [Related]
15. Doxorubicin cardiomyopathy: evaluation by phonocardiography, endomyocardial biopsy, and cardiac catheterization. Bristow MR; Mason JW; Billingham ME; Daniels JR Ann Intern Med; 1978 Feb; 88(2):168-75. PubMed ID: 626445 [TBL] [Abstract][Full Text] [Related]
16. Dose-effect and structure-function relationships in doxorubicin cardiomyopathy. Bristow MR; Mason JW; Billingham ME; Daniels JR Am Heart J; 1981 Oct; 102(4):709-18. PubMed ID: 7282516 [TBL] [Abstract][Full Text] [Related]